Trial Details

COMPLETED
Basic Information
Clinical ID c4628
Identifier NCT00232258
Trial Title Nolpitantium Besylate In Patients With Ulcerative Colitis a Double-Blind, Placebo Controlled Efficacy and Safety Study
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Ulcerative Colitis|Inflammatory Bowel Disease
Interventions DRUG: Nolpitantium besylate
Participant Information
Sponsor Sanofi
City Buenos Aires
Country/Region Argentina
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2005-04
Primary Completion Date 2006-09
Completion Date 2006-09